Ranbaxy Laboratories Ltd (Merged)

Ranbaxy Labs. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Ranbaxy Laboratories Ltd (Merged)

₹ 860 5.63%
01 Apr 2015
Company website BSE: 500359
About

Ranbaxy Laboratories Limited,Incorporated in India, listed on the Bombay Stock Exchange Limited, and National Stock Exchange Limited, the company is engaged in Pharmaceutical

[ add key points ]
Website BSE
  • Market Cap ₹ Cr.
  • Current Price ₹ 860
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ 86.0
  • Dividend Yield 0.00 %
  • ROCE 7.18 %
  • ROE -17.5 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Debtor days have improved from 74.3 to 57.0 days.

Cons

  • Stock is trading at 9.99 times its book value
  • Company has low interest coverage ratio.
  • Company has a low return on equity of 9.24% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2011 Mar 2012 Jun 2012 Sep 2012 Dec 2012 Mar 2013 Jun 2013 Sep 2013 Dec 2013 Mar 2014 Jun 2014 Sep 2014 Dec 2014
3,826 3,781 3,259 2,708 2,711 2,472 2,634 2,802 2,894 2,467 2,416 3,260 2,619
3,028 2,690 2,998 2,372 2,658 2,317 2,511 2,602 2,624 2,413 2,286 2,555 2,506
Operating Profit 798 1,091 261 336 53 155 123 199 270 54 130 705 113
OPM % 21% 29% 8% 12% 2% 6% 5% 7% 9% 2% 5% 22% 4%
-3,443 405 -530 459 -289 144 -451 -346 -119 89 -181 -5 -5
Interest 91 19 165 -16 136 53 159 111 121 114 142 137 147
Depreciation 168 80 78 0 80 80 0 133 92 0 0 0 97
Profit before tax -2,903 1,398 -512 811 -453 167 -487 -391 -60 30 -192 563 -135
Tax % 3% 10% 13% 7% 8% 21% 6% 15% 163% 371% -3% 15% 656%
-2,980 1,248 -584 757 -489 130 -523 -453 -162 -79 -189 477 -1,024
EPS in Rs -70.68 29.54 -13.88 17.86 -11.64 2.97 -12.39 -10.73 -3.75 -1.74 -4.39 11.27 -24.23
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Dec 2005 Dec 2006 Dec 2007 Dec 2008 Dec 2009 Dec 2010 Dec 2011 Dec 2012 Mar 2014 15m TTM
5,134 6,057 6,684 7,296 7,515 8,876 10,315 12,452 13,259 10,762
5,022 5,276 6,143 8,756 6,924 7,806 8,861 10,647 12,281 9,760
Operating Profit 112 781 540 -1,460 591 1,070 1,455 1,805 977 1,002
OPM % 2% 13% 8% -20% 8% 12% 14% 14% 7% 9%
259 123 771 448 758 1,463 -3,441 64 -686 -100
Interest 67 104 141 206 71 61 306 304 557 540
Depreciation 109 149 172 282 268 372 394 320 476 97
Profit before tax 194 651 999 -1,500 1,010 2,100 -2,686 1,245 -742 265
Tax % -36% 21% 21% -38% 69% 28% 7% 24% 45%
264 515 787 -943 307 1,509 -2,890 932 -1,087 -815
EPS in Rs 13.69 20.76 -22.63 7.05 35.55 -68.71 21.82 -25.61 -19.09
Dividend Payout % 121% 62% 41% 0% 0% 6% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 13%
3 Years: 14%
TTM: 0%
Compounded Profit Growth
10 Years: %
5 Years: 7%
3 Years: %
TTM: -158%
Stock Price CAGR
10 Years: 0%
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 13%
3 Years: 9%
Last Year: -18%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Dec 2005 Dec 2006 Dec 2007 Dec 2008 Dec 2009 Dec 2010 Dec 2011 Dec 2012 Mar 2014
Equity Capital 186 186 187 210 210 211 211 211 212
Reserves 2,261 2,400 2,617 4,086 4,133 5,394 2,658 3,873 3,091
2,004 3,956 4,142 4,285 3,630 4,335 4,491 4,901 6,598
1,517 1,891 2,333 4,656 4,165 4,205 8,352 7,466 4,077
Total Liabilities 5,969 8,432 9,278 13,237 12,137 14,144 15,712 16,452 13,978
2,059 3,895 4,205 4,490 4,490 4,548 4,830 5,008 5,081
CWIP 560 358 357 471 623 382 227 208 303
Investments 17 36 240 543 541 498 98 79 72
3,333 4,143 4,476 7,733 6,483 8,716 10,557 11,157 8,522
Total Assets 5,969 8,432 9,278 13,237 12,137 14,144 15,712 16,452 13,978

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Dec 2005 Dec 2006 Dec 2007 Dec 2008 Dec 2009 Dec 2010 Dec 2011 Dec 2012 Mar 2014
204 529 1,023 -152 -162 1,539 639 1,582 -3,562
-838 -1,993 -841 -1,776 54 -2,196 1,781 -1,871 1,958
746 1,513 -39 2,676 -522 791 -1,218 237 1,016
Net Cash Flow 112 49 143 749 -631 134 1,202 -52 -588

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Dec 2005 Dec 2006 Dec 2007 Dec 2008 Dec 2009 Dec 2010 Dec 2011 Dec 2012 Mar 2014
Debtor Days 81 95 82 67 89 66 106 60 57
Inventory Days 224 248 220 234 219 266 286 246 209
Days Payable 127 130 116 133 171 230 156 146 111
Cash Conversion Cycle 178 213 186 168 137 102 236 159 154
Working Capital Days 113 124 104 -24 32 53 1 -18 56
ROCE % 14% 16% -18% 12% 21% 15% 21% 7%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents

Announcements

All

No data available.

Annual reports